Chester Joyner
Dr. Chet Joyner is a trained immunologist and parasitologist. His research program focuses on understanding the biology of Plasmodium vivax, malaria immunology and pathogenesis, and the biology of B cells and plasma cells. The ultimate goals of his research is to use cutting-edge technologies to help development new treatments and […]
Karen A. Norris
Karen Norris, PhD, received her doctorate in biomedical sciences and microbiology from Wright State University School of Medicine and completed post-doctoral training at The Scripps Research Institute. Dr. Norris was appointed as Assistant Professor in Molecular Genetics and Biochemistry at the University of Pittsburgh, then joined the newly formed Department […]
Yung-Yi Mosley
BVM, MS, PhD, Diplomate ACVM Dr. Mosley is from Taiwan where she earned her Bachelor of Veterinary Medicine and Master of Science from National Chung Hsing University. Later she got her PhD degree from Purdue University in Virology & Vaccinology. She is a board certified Veterinary Microbiologist with experience of […]
Ralph A. Tripp
Dr. Ralph Tripp is a Professor in the Department of Infectious Diseases in the College of Veterinary Medicine and is a Georgia Research Alliance Eminent Scholar in Vaccine and Therapeutics. Dr. Tripp was trained in the field of viral immunity with Laureate Professor Peter C. Doherty and led a research […]
Biao He
Dr. He’s lab has been studying paramyxoviruses including PIV5, mumps virus and emerging Jeilongviruses. His work has led to development of paramyxovirus-based vaccines
Mary Hondalus
Dr. Hondalus is a graduate from the College of Veterinary Medicine at Michigan State University, and following graduation, she was an equine and small animal private practitioner. She subsequently completed a Large Animal Internal Medicine Residency at Tufts University School of Veterinary Medicine and a PhD in Microbiology and Immunology […]
Eric R. Lafontaine
One component of my research program consists of identifying and characterizing surface antigens expressed by pathogenic bacteria including Burkholderia pseudomallei and Burkholderia mallei. Given their cellular location at the host-pathogen interface, surface antigens play key roles in bacterial virulence. We believe that studying their biological functions will shed light on […]
Frederick D. Quinn
Frederick D. Quinn, Ph.D., is Athletic Association Professor of Infectious Diseases, Head of the Department of Infectious Diseases and Interim Director of the Center for Vaccines and Immunology in the College of Veterinary Medicine at the University of Georgia. Dr. Quinn oversaw several laboratory groups at the Centers for Disease […]
S. Mark Tompkins
Mark Tompkins is the Director and Principal Investigator of the Center for Influenza Disease and Emergence Research, a NIAID Center of Excellence in Influenza Research and Response (CEIRR) at the University of Georgia. He received his doctorate in Immunology from Emory University and then studied immune mechanisms of autoimmune diseases […]
Ankita Garg
Dr. Garg received Ph.D. in Medical Microbiology from Sanjay Gandhi Postgraduate Institute of Medical Science, India, followed by postdoctoral training from the University of Texas Health Science Center and the University of California, San Diego. Dr. Garg also spent a few years in the R&D divisions of pharmaceutical companies where […]
Robert Jeffrey Hogan
Dr. Hogan began his 30 year scientific career studying host-pathogen interactions during his graduate studies, which focused on immune responses to viral infection in teleosts. After receiving his doctoral degree, he joined the laboratory of Dr. David Woodland at St. Jude Children’s Research Hospital, where his research focused on cell-mediated […]
Tuhina Gupta
Dr. Tuhina Gupta is an immunologist and a bacteriologist, with expertise in mycobacterial diseases. She joined the University of Georgia in 2007 and works with Dr. Frederick Quinn on multiple projects. Her research focuses on developing animal models of mycobacterial pathology, meningitis, latency, and transmission, testing novel methods for TB […]
Leslie P. Jones
My research interests include the development of novel antiviral therapeutic agents, as well as the re-purposing of existing therapies applied to counter viral infection. Host cells, triggered by virus infection, induce multiple anti-viral and pro-viral pathways utilized, suppressed or evaded by viruses presenting potential druggable host targets. Our lab studies […]
Russell Karls
Dr. Karls is a Senior Research Scientist in the Infectious Diseases Department at the University of Georgia. He received undergraduate degrees in Biochemistry and Bacteriology from the University of Wisconsin-Madison. He earned his doctorate in Bacteriology from UW-Madison applying biochemistry and molecular genetics to study transcriptional control of bacterial photosynthesis. […]
M. Stephen Trent
Understanding the bacterial cell envelope provides valuable insights for two crucial areas: the discovery of new antibiotics and the understanding of microbe-host interactions. The cell envelope serves as a prime target for antibiotic development, as its unique components and processes can be exploited to disrupt bacterial growth and survival. By […]
Ashutosh Pathak
I am interested in determining how parasite fitness is shaped by interactions with host(s) and environment. Questions that motivate my research include: 1) How do biotic and abiotic factors regulate dynamics of parasite populations within and between hosts? 2) To what extent do parasites and their hosts vary naturally in […]
Whitney Rabacal
Whitney Rabacal obtained her Bachelor’s degree from Bowdoin College (Brunswick, ME) in 2006 and then worked as a research assistant at Brigham and Women’s Hospital (Boston, MA) in the laboratory Dr. Vicki Rubin Kelley from 2016-2010, focusing on models of autoimmune kidney disease. In 2016, Dr. Rabacal then received her […]
Jarrod J. Mousa
Jarrod Mousa received his PhD from the University of Florida where he studied the structure and mechanism of multidrug transporters in pathogenic bacteria. He then completed a postdoctoral fellowship at Vanderbilt University in the Vaccine Center where he studied the human antibody response to respiratory syncytial virus. Dr. Mousa joined […]
